Sotirios A Parashos
Overview
Explore the profile of Sotirios A Parashos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wills A, Elm J, Ye R, Chou K, Parashos S, Hauser R, et al.
Parkinsonism Relat Disord
. 2016 Oct;
33:127-133.
PMID: 27743701
Introduction: Clinical cohort studies suggest that mild cognitive impairment (MCI) is common in early Parkinson's disease (PD). The objectives of this paper were to describe cognitive function in a large...
12.
Parashos S, Elm J, Boyd J, Chou K, Dai L, Mari Z, et al.
J Parkinsons Dis
. 2014 Oct;
5(1):67-73.
PMID: 25311202
Background: A construct calculated as the sum of items 13-15, 29, 30 of the Unified Parkinson's Disease Rating Scale (UPDRS) has been used as an "Ambulatory Capacity Measure" (ACM) in...
13.
Parashos S, Luo S, Biglan K, Bodis-Wollner I, He B, Liang G, et al.
JAMA Neurol
. 2014 Apr;
71(6):710-6.
PMID: 24711047
Importance: Optimizing assessments of rate of progression in Parkinson disease (PD) is important in designing clinical trials, especially of potential disease-modifying agents. Objective: To examine the value of measures of...
14.
Parashos S, Wielinski C, Giladi N, Gurevich T
J Parkinsons Dis
. 2013 Oct;
3(4):515-22.
PMID: 24113557
Background: Falls remain a significant cause of morbidity in PD. Risk factors are not well understood. Objective: In this study we explore risk factors for falls in PD utilizing the...
15.
16.
Chou K, Zamudio J, Schmidt P, Price C, Parashos S, Bloem B, et al.
Parkinsonism Relat Disord
. 2011 Apr;
17(6):440-5.
PMID: 21458353
Objectives: To explore current practices and opinions regarding hospital management of Parkinson disease (PD) patients in specialized PD Centers. Methods: Fifty-one out of 54 National Parkinson Foundation (NPF) Centers worldwide...
17.
Aminoff M, Christine C, Friedman J, Chou K, Lyons K, Pahwa R, et al.
Parkinsonism Relat Disord
. 2010 Dec;
17(3):139-45.
PMID: 21159538
Objective: To review the literature and to identify practice gaps in the management of the hospitalized Parkinson's disease (PD) patient. Background: Patients with PD are admitted to hospitals at higher...
18.
Schneider J, Elm J, Parashos S, Ravina B, Galpern W
Parkinsonism Relat Disord
. 2010 Jul;
16(8):507-12.
PMID: 20598621
Cognitive dysfunction is an important aspect of Parkinson disease (PD) and is increasingly being examined in various large scale PD clinical studies. However, the sensitivity of some of the cognitive...
19.
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects
Lyons K, Friedman J, Hermanowicz N, Isaacson S, Hauser R, Hersh B, et al.
Clin Neuropharmacol
. 2009 Oct;
33(1):5-10.
PMID: 19855267
Objective: To determine whether adding orally disintegrating selegiline (ODS) while decreasing dopamine agonist (DA) dosages would reduce DA-related adverse effects (AEs) of excessive daytime sleepiness (EDS), pedal edema, hallucinations, and...
20.
Parashos S, Johnson M, Erickson-Davis C, Wielinski C
J Geriatr Psychiatry Neurol
. 2009 Aug;
22(4):228-34.
PMID: 19666882
Objective: To evaluate the Cognitive Linguistic Quick Test (CLQT) as a cognitive screening tool in Parkinson disease (PD). Methods: A total of 93 patients with PD were evaluated with the...